These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24005901)

  • 21. [Screening of athletes prevents sudden cardiac death].
    Panhuyzen-Goedkoop NM
    Ned Tijdschr Geneeskd; 2012; 156(31):A4895. PubMed ID: 22853772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy.
    Robyns T; Nuyens D; Lu HR; Gallacher DJ; Vandenberk B; Garweg C; Ector J; Pagourelias E; Van Cleemput J; Janssens S; Willems R
    J Electrocardiol; 2018; 51(6):1077-1083. PubMed ID: 30497734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases.
    Allegue C; Gil R; Blanco-Verea A; Santori M; Rodríguez-Calvo M; Concheiro L; Carracedo A; Brion M
    Int J Legal Med; 2011 Jul; 125(4):565-72. PubMed ID: 21499742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness and diagnostic accuracy of focused cardiac ultrasound in the pre-participation screening of athletes: the SPORT-FoCUS study.
    Halasz G; Capelli B; Nardecchia A; Cattaneo M; Cassina T; Biasini V; Barbieri D; Villa M; Beltrami M; Perone F; Villani M; Badini M; Gervasi F; Piepoli M; Via G
    Eur J Prev Cardiol; 2023 Nov; 30(16):1748-1757. PubMed ID: 37668353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal.
    Magrì D; Santolamazza C; Limite L; Mastromarino V; Casenghi M; Orlando P; Pagannone E; Musumeci MB; Maruotti A; Ricotta A; Oliviero G; Piccirillo G; Volpe M; Autore C
    J Cardiol; 2017 Oct; 70(4):310-315. PubMed ID: 28341542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
    Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
    Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and objectives for ECG screening in infancy.
    Saul JP; Schwartz PJ; Ackerman MJ; Triedman JK
    Heart Rhythm; 2014 Dec; 11(12):2316-21. PubMed ID: 25239430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac death in young competitive athletes due to genetic cardiac abnormalities.
    Wever-Pinzon OE; Myerson M; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():17-23. PubMed ID: 20089483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of electrocardiographic screening failure for the subcutaneous implantable cardioverter-defibrillator in children: A prospective multicenter study.
    Campbell M; Moore JP; Sreeram N; von Alvensleben JC; Shah A; Batra A; Law I; Sanatani S; Thomas V; Nik-Ahd F; Williams S; Nosavan N; Maldonado J; Hart A; Nguyen T; Balaji S
    Heart Rhythm; 2018 May; 15(5):703-707. PubMed ID: 29309839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs?
    Earle N; Crawford J; Smith W; Hayes I; Shelling A; Hood M; Stiles M; Maxwell F; Heaven D; Love DR; Skinner JR
    Heart Rhythm; 2013 Feb; 10(2):233-8. PubMed ID: 23123674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using a smartwatch electrocardiogram to detect abnormalities associated with sudden cardiac arrest in young adults.
    Nasarre M; Strik M; Daniel Ramirez F; Buliard S; Marchand H; Abu-Alrub S; Ploux S; Haïssaguerre M; Bordachar P
    Europace; 2022 Mar; 24(3):406-412. PubMed ID: 34468759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of in-home automated external defibrillators for children with cardiac conditions associated with risk of sudden cardiac death.
    Haag MB; Hersh AR; Toffey DE; Sargent JA; Stecker EC; Heitner SB; Caughey AB; Balaji S
    Heart Rhythm; 2020 Aug; 17(8):1328-1334. PubMed ID: 32234558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
    Wordsworth S; Leal J; Blair E; Legood R; Thomson K; Seller A; Taylor J; Watkins H
    Eur Heart J; 2010 Apr; 31(8):926-35. PubMed ID: 20299350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults.
    Magnusson P; Wimo A
    Int J Cardiol; 2020 Jul; 311():46-51. PubMed ID: 32122698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol.
    Ng CT; Chee TS; Ling LF; Lee YP; Ching CK; Chua TS; Cheok C; Ong HY
    Europace; 2011 Jun; 13(6):883-8. PubMed ID: 21486912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
    Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart.
    Calore C; Zorzi A; Corrado D
    J Electrocardiol; 2015; 48(3):373-9. PubMed ID: 25595718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden cardiac death in young athletes: trying to find the needle in the haystack.
    Ng B; Maginot KR
    WMJ; 2007 Sep; 106(6):335-42. PubMed ID: 17970016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.